TCM Life Science

About

TCM Life Science filed an SEC Form D on 2026-10-26. The filing reports $16,666 raised and gives Delaware as the state. The industry on the filing is Biotechnology. Related persons named on the filing: Ya-Chun Wang (executive officer, director, Newark, Delaware); Huan-Chin Hsu (director, Newark, Delaware). The legal name on the form is TCM Life Science Inc.. Filing: https://www.sec.gov/Archives/edgar/data/2160964/000216096426000001/0002160964-26-000001-index.htm

The offering amount is indefinite and is not stored as a number. The page stores Delaware and does not store the issuer city as a headquarters. EDGAR lists this as the only Form D. This is the issuer's first Form D.

This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.

Funding history

Sources

Last verified: 2026-10-27

1. https://www.sec.gov/Archives/edgar/data/2160964/000216096426000001/0002160964-26-000001-index.htm
   Type: sec filing. Accessed 2026-10-27.
   SEC Form D for TCM Life Science Inc. EDGAR filing date 2026-10-26. Signed 2026-10-26 by Ya-Chun Wang, President. First sale 2026-10-12. Total amount sold $16,666. The offering amount is indefinite and is not stored as a number. 2 investors already invested. Issuer address city is Newark, Delaware. Jurisdiction on the form: Delaware. Year of incorporation on the form: 2026. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. The form's security types are equity. EDGAR lists this as the only Form D. This is the issuer's first Form D.
2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-27/
   Type: other verified public source. Accessed 2026-10-27.
   Raise Track Update for 2026-10-27, Section 3. Lists TCM Life Science in Delaware, industry Biotechnology, amount raised $16,666.